• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

TB Saracen Global Income & Growth B Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Saracen
Fund Summary The objective is to provide a degree of income to investors together with the aim of building capital.
SEDOL code B5B35X0
ISIN GB00B5B35X02
Fund code SRGBA
Managers Graham Campbell, David Keir
Manager Tenure 8 years
Morningstar Category Global Equity Income
IMA Sector Global Equity Income
Fund Size £116 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.97%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £2.1003
Buy Price £2.1003
Price Change -0.37%
Price Date 20th September 2019
Yield 3.30%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 7th June 2011
Fund Status OPEN

3-year Mean Monthly Return: 0.554%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011
Fund Performance +3.55% +2.27% +28.88% +5.63% +3.19% +10.93% +27.16% +1.24%
Benchmark Performance
(Global Equity Income)
+8.16% +0.52% +23.00% +8.23% +7.43%
Time Period Cumulative Benchmark Performance
(Global Equity Income)
Fund Compared to Benchmark
1 day -0.37% -0.18% -0.19%
1 week -1.64% -0.67% -0.97%
1 month 2.21% +0.50% +1.72%
3 months -0.85% +2.09% -2.94%
6 months 2.30% +8.10% -5.80%
1 year -0.83% +7.14% -7.97%
3 years 22.95% +26.84% -3.89%
5 years 45.05% +55.59% -10.55%
10 years Currently unavailable +149.27% Currently unavailable
YTD 12.46% +16.23% -3.77%
Since inception 110.03% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Roche Holding AG Dividend Right Cert. CHE 4.78%
DowDuPont Inc USA 3.85%
Johnson & Johnson USA 3.71%
HeidelbergCement AG DEU 3.71%
Imperial Brands PLC GBR 3.69%
Merck & Co Inc USA 3.68%
UBS Group AG CHE 3.63%
Svenska Handelsbanken A SWE 3.52%
Johnson Matthey PLC GBR 3.42%
Pfizer Inc USA 3.39%
Dividend Date Per share amount Reinvestment Price
1st July 2019 0.0496 £2.1556
2nd January 2019 0.0271 £1.8727
2nd July 2018 0.0399 £2.0343
2nd January 2018 0.0169 £2.0817
3rd July 2017 0.0353 £2.0048
3rd January 2017 0.0493 £1.8912